Gangliosidosis Latest Advances
Find the Latest Research About Gangliosidosis
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2981 publications
Pyrimethamine-based targeting of HEXA gene mutations in Tay-Sachs disease: a computational analysis.
Pyrimethamine-based targeting of HEXA gene mutations in Tay-Sachs disease: a computational analysis.
Journal: Journal of biomolecular structure & dynamics
Published: February 20, 2026
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.
Journal: The New England journal of medicine
Published: February 10, 2026
Correction: Vyas et al. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. Int. J. Mol. Sci. 2023, 24, 14611.
Journal: International journal of molecular sciences
Published: January 17, 2026
Bilateral Macular Cherry-Red Spots in Infantile Sandhoff Disease.
Journal: Ophthalmology. Retina
Published: January 15, 2026
Novel Galactosidase-Beta-1 Variant in Infantile GM1 Gangliosidosis: A Case Report.
Journal: Cureus
Published: January 15, 2026
Tay-Sachs disease models: From cellular and animal models to treatment perspectives.
Journal: Molecular genetics and metabolism
Published: January 15, 2026
B4Galnt1 Deficiency Reverses Severe Neurological Symptoms in a Mouse Model of Tay-Sachs Disease.
Journal: Neuromolecular medicine
Published: January 04, 2026
Correction to 'A novel HEXA frameshift mutation identified in Angus cattle with GM2 gangliosidosis'.
Correction to 'A novel HEXA frameshift mutation identified in Angus cattle with GM2 gangliosidosis'.
Journal: Animal genetics
Published: January 04, 2026
Clinical, Radiological, and Genetic Profiles of Eight Patients with Combined Dystonic Manifestation of Type-III GM1 Gangliosidosis: A Video Case Series from India.
Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: December 08, 2025
Symptomatic Benefit of Acetyl-DL-Leucine for Cerebellar Ataxia in Juvenile Tay-Sachs Disease: A Pediatric Case and Literature Review.
Journal: Molecular syndromology
Published: November 25, 2025
Generation and characterization of induced pluripotent stem cell (iPSC) lines from patients affected with Tay-Sachs and Sandhoff disease.
Journal: Stem cell research
Published: November 19, 2025
Human Neuraminidase 3 reduces the severity of Tay-Sachs disease symptoms in a mouse model.
Journal: Neurochemistry international
Published: November 17, 2025
Last Updated: 04/28/2026